Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
86.53
+0.32 (0.37%)
Dec 20, 2024, 4:00 PM EST - Market closed
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $10.78 billion as of December 20, 2024. Its market cap has increased by 99.61% in one year.
Market Cap
10.78B
Enterprise Value
8.63B
1-Year Change
99.61%
Ranking
Category
Stock Price
$86.53
Market Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from $1.38B to $10.78B, an increase of 681.53%. That is a compound annual growth rate of 57.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 10.78B | 80.48% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.58% |
| Dec 31, 2021 | 1.26B | -7.24% |
| Dec 31, 2020 | 1.35B | -1.90% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Universal Health Services | 11.60B |
| Solventum | 11.54B |
| Sarepta Therapeutics | 11.41B |
| Bio-Techne | 11.34B |
| Globus Medical | 11.16B |
| Smith & Nephew | 10.70B |
| AptarGroup | 10.57B |
| Medpace Holdings | 10.39B |